JESSICA NAVARRO: Open Payments
NPI 1104499292 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 65 payments from 18 companies in 2025. Trend: 2023 $1,949 · 2024 $1,771 · 2025 $1,573
Food & beverage: $1,399Education: $174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $359 |
| Janssen Biotech, Inc. | 8 | $250 |
| Novartis Pharmaceuticals Corporation | 10 | $173 |
| Gilead Sciences, Inc. | 1 | $114 |
| PFIZER INC. | 6 | $102 |
| GENZYME CORPORATION | 3 | $98 |
| LEO Pharma Inc. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Lilly USA, LLC | 2 | $51 |
| Amgen Inc. | 2 | $49 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Livdelzi, CIBINQO, ADBRY, COSENTYX, RINVOQ.
Industry payments across FL — which companies pay providers there.
